Human bocavirus (HBoV) was detected in 14 (2%) of 705 fecal specimens from Brazilian children with gastroenteritis. Coinfection with rotavirus, adenovirus, or norovirus was found in 3 (21.4%) HBoV-positive specimens. None of the HBoV-positive patients had respiratory symptoms.
: Our data demonstrate the reemergence of RV-A genotype G2P[4] in Brazil from 2005 to 2008, and that the rate of G2P[4] detection decreased in 2009, probably reflecting natural oscillations of RV-A genotypes.
During 1998–2005, we analyzed stool samples from 289 children in Rio de Janeiro to detect and genotype norovirus strains. Previous tests showed all samples to be negative for rotavirus and adenovirus. Of 42 (14.5%) norovirus-positive specimens, 20 (47.6%) were identified as genogroup GI and 22 (52.3%) as GII.
Rotavirus diarrhea is a potentially life-threatening disease that affects millions of children annually around the world. Because protection against rotavirus disease is thought to be type specific, continuous rotavirus surveillance before and after implementation of a vaccine is still of essential importance. Rotavirus surveillance has been conducted in the city of Rio de Janeiro, Brazil since 1982. In the present study, we report rotavirus surveillance data in Rio de Janeiro city from 2000 to 2004. One hundred twenty nine of 1,568 (8.2%) stool samples, collected from children with acute diarrhea between January 2000 and July 2004 were rotavirus-positive. One hundred twenty eight of the 129 (99.2%) rotavirus-positive samples were genotyped for G and/or P specificity. G1 was the predominant strain (49.6%, 64/129) followed by G9 (30.2%, 39/129), and G4 (17.8%, 23/129); G2 and G3 viruses were not detected. One sample (0.8%) was non-typeable. P genotypes were determined for 124 of the 129 (96%) samples, and P[8] was the predominant genotype (90.6%, 117/129). Genotypes P[4] and P[9] were detected in two (1.6%) samples each; one (0.8%) sample presented P[6] genotype; and five (3.8%) samples were non-typeable. Two samples (1.6%) presented mixed P genotypes (P[6] + P[8]). Two unusual strains were isolated: a G8P[4] strain isolated from a non-hospitalized child with diarrhea and a G10P[9] strain isolated from a hospitalized child with diarrhea.
We analyzed 379 stool samples collected from January 1998 through December 2004, from hospitalized and non-hospitalized children with diarrhea in Rio de Janeiro, Brazil. These samples had prior negative results for other enteric viruses and bacterial pathogens. The specimens were analyzed for HAstV detection by RT-PCR. HAstV genotypes were determined by sequence analysis of the RT-PCR products. Twenty (5.3%) out of 379 samples were positive for astrovirus. Astrovirus was equally common among inpatients and outpatients and among different age groups. Of 20 HAstV-infected children, 13 (65%) were either hospitalized or received medical care in the emergence department, which suggests that they had a more severe illness. Only 7 (35%) of the 20 HAstV-infected children attended walk-in clinics, which suggests that they had mild disease. Other then diarrhea, fever was the most common symptom among the HAstV-positive patients, followed by vomit and bloody diarrhea. HAstV-1 was the predominant strain although genotypes 2 and 4 were also found. There was no obvious difference among HAstV strains detected from inpatients or outpatients or among different age groups. The study documented that astrovirus is an agent of acute diarrhea in children who are inpatients or outpatients in Rio de Janeiro, Brazil although it seems to be less common as a single cause of childhood diarrhea then rotavirus.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.